Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 12:44 AM
NCT ID:
NCT01057667
Eligibility Criteria:
Inclusion Criteria:
* adult patients, 18-70 years of age
* hepatitis C, genotype 1 or 4, of over 6 months duration
* treatment-naïve
* negative pregnancy test; female patients of childbearing age and male patients with female partners of childbearing age must use two forms of contraception during treatment and following the last dose of ribavirin in accordance with locally approved label for ribavirin
Exclusion Criteria:
* pregnant or breast feeding females or male partners of pregnant females
* previous interferon or ribavirin based therapy or investigational anti-HCV agent
* systemic antiviral therapy with established or perceived activity against HCV \</=3 months prior to first dose of study drug
* hepatitis A or B, or HIV infection
* history or evidence of medical condition associated with chronic liver disease other than HCV
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01057667
Study Brief:
Protocol Section:
NCT01057667